Literature DB >> 19342466

The calibration of treatment effects from clinical trials to target populations.

Constantine Frangakis.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19342466      PMCID： PMC4137779          DOI： 10.1177/1740774509103868

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  4 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?

Authors:  Herbert I Weisberg; Vanessa C Hayden; Victor P Pontes
Journal:  Clin Trials       Date:  2009-04       Impact factor: 2.486

Review 3.  Surrogate end points in clinical trials: are we being misled?

Authors:  T R Fleming; D L DeMets
Journal:  Ann Intern Med       Date:  1996-10-01       Impact factor: 25.391

4.  Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.

Authors:  Miguel A Hernán; Alvaro Alonso; Roger Logan; Francine Grodstein; Karin B Michels; Walter C Willett; Joann E Manson; James M Robins
Journal:  Epidemiology       Date:  2008-11       Impact factor: 4.822
  4 in total
  24 in total

1.  Transportability of Trial Results Using Inverse Odds of Sampling Weights.

Authors:  Daniel Westreich; Jessie K Edwards; Catherine R Lesko; Elizabeth Stuart; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2017-10-15       Impact factor: 4.897

2.  Invited commentary: every good randomization deserves observation.

Authors:  Daniel Westreich; Jessie K Edwards
Journal:  Am J Epidemiol       Date:  2015-10-19       Impact factor: 4.897

3.  The use of propensity scores to assess the generalizability of results from randomized trials.

Authors:  Elizabeth A Stuart; Stephen R Cole; Catherine P Bradshaw; Philip J Leaf
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2001-04-01       Impact factor: 2.483

4.  Person mobility in the design and analysis of cluster-randomized cohort prevention trials.

Authors:  Sam Vuchinich; Brian R Flay; Lawrence Aber; Leonard Bickman
Journal:  Prev Sci       Date:  2012-06

5.  EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY.

Authors:  Lihui Zhao; Lu Tian; Tianxi Cai; Brian Claggett; L J Wei
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

6.  Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Authors:  Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2010-06-14       Impact factor: 4.897

7.  Constrained Maximum Likelihood Estimation for Model Calibration Using Summary-level Information from External Big Data Sources.

Authors:  Nilanjan Chatterjee; Yi-Hau Chen; Paige Maas; Raymond J Carroll
Journal:  J Am Stat Assoc       Date:  2016-05-05       Impact factor: 5.033

8.  Robust estimation of encouragement-design intervention effects transported across sites.

Authors:  Kara E Rudolph; Mark J van der Laan
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2016-10-31       Impact factor: 4.488

9.  The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11.

Authors:  Catherine R Lesko; Stephen R Cole; H Irene Hall; Daniel Westreich; William C Miller; Joseph J Eron; Jianmin Li; Michael J Mugavero
Journal:  Int J Epidemiol       Date:  2016-01-15       Impact factor: 7.196

10.  A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes.

Authors:  David Arterburn; David R Flum; Emily O Westbrook; Sharon Fuller; Mary Shea; Steven N Bock; Jeffrey Landers; Katie Kowalski; Emily Turnbull; David E Cummings
Journal:  Surg Obes Relat Dis       Date:  2013-06-04       Impact factor: 4.734
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.